IP Verse

Therapeutic Uses Of 1-[2-(2,4-Dimethyl-Phenylsulfanyl)Phenyl]Piperazine - EP2608789

The patent EP2608789 was granted to H Lundbeck on Aug 21, 2024. The application was originally filed on Aug 22, 2011 under application number EP11749331A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2608789

H LUNDBECK
Application Number
EP11749331A
Filing Date
Aug 22, 2011
Status
Patent Maintained As Amended
Jul 19, 2024
Grant Date
Aug 21, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HEXALJan 11, 2018KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO0229232
DESCRIPTIONWO03029232
DESCRIPTIONWO2007144005
DESCRIPTIONWO2008113359
DESCRIPTIONWO2009062517
EXAMINATIONUS4745122
INTERNATIONAL-SEARCH-REPORTWO2007144005
INTERNATIONAL-SEARCH-REPORTWO2009062517
OPPOSITIONWO03029232
OPPOSITIONWO2007144005
OPPOSITIONWO2009062517

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- KELLY KAREN ET AL, "Toward achieving optimal response: understanding and managing antidepressant side effects.", DIALOGUES IN CLINICAL NEUROSCIENCE 2008, (2008), vol. 10, no. 4, ISSN 1294-8322, pages 409 - 418, XP009189114-
OPPOSITION- A. SERRETTI et al., "Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis", J. Clin. Psychiatry, (20101000), vol. 71, no. 10, pages 1259 - 1272, XP055452724-
OPPOSITION- M. FAVA, "Weight Gain and Antidepressants", J. Clin. Psychiatry, (20000000), vol. 61, no. 11, pages 37 - 41, XP055452718-
OPPOSITION- P. S. MASAND, "Weight gain associated with psychotropic drugs", E xp. Opin. Pharmacother, (20000000), vol. 1, no. 3, pages 377 - 389, XP055452721-
OPPOSITION- P. S. MASAND, "Weight gain associated with psychotropic drugs", E xp. Opin. Pharmacother, (2000), vol. 1, no. 3, pages 377 - 389, XP055452721-
OPPOSITION- F. ARTIGAS et al., "A randomised, double-blind, placebo-controlled, active-referenced study of Lu AA21004 in patients with major depression", European Neuropsychopharmacology, Amsterdam, NL, (20090901), vol. 19, pages S426 - S427, XP026717401

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents